GlassScriptPhysician profile
Jose B Lopez
NPI 1154305241
$955.86
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $11.79 · 2021: $274 · 2022: $424 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $305.39 | 2019-2023 | Ozempic, Rybelsus |
| Dexcom, INC. | $161.60 | 2021 | |
| Sunovion Pharmaceuticals INC. | $75.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $74.52 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $71.73 | 2021-2022 | |
| Abbvie INC. | $69.49 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $58.48 | 2022-2023 | Rexulti |
| Axsome Therapeutics, INC. | $32.92 | 2022-2023 | Auvelity |
| Glaxosmithkline, LLC. | $30.65 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.42 | 2022-2023 | Breztri |
| Sanofi Pasteur INC. | $19.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.